Category: Philips HealthcareSyndicate content

Masimo wins $467m verdict in patent spat with Philips

October 2, 2014 by Alexander Soule

A jury delivers a $467 million verdict for Masimo in a patent infringement spat with Royal Philips over pulse oximetry technology.

Masimo wins $467m verdict in patent spat with Philips

TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014

September 25, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units

TriVascular Tech's stent graft recall could hurt the bottom line

September 19, 2014 by Arezu Sarvestani

TriVascular Tech's stent graft recall could hurt the bottom line

Zoll, Philips win Defense Dept. contracts

September 25, 2014 by Alexander Soule

The U.S. Defense Dept. awards rivals Philips Healthcare and Zoll Medical separate contracts to supply airworthy defibrillators.

Zoll, Philips win Defense Dept. contracts

Philips to carve out lighting biz, merger healthcare & consumer units

September 23, 2014 by Alexander Soule

Royal Philips reveals plans to spin out its legacy lighting business and merge Philips Healthcare and its consumer business into a new 'HealthTech' unit.

Philips to carve out lighting biz, merger healthcare & consumer units

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

September 2, 2014 by Brad Perriello

Bluegrass Vascular Technologies taps former ArthroCare R&D chief Gabriele Niederauer to be its new president & CEO.

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.

Appeals court denies Zoll challenge to Philips AED patents

August 28, 2014 by Brad Perriello

A federal appeals court upholds the U.S. Patent & Trademark Office's decision not to review 8 defibrillator patents owned by Philips Healthcare and dismisses the case.

Appeals court denies Zoll challenge to 8 Philips patents

FDA grants Philips clearance for 3D TAVI software | Regulatory news for the week of August 25, 2014

August 26, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Philips wins FDA nod for 3D TAVI planning software; Direct Flow wins CE Marks for TAVI device; FDA OKs return of Covidien's Pipeline embolism device; FDA delays UDI rule for contacts, intraocular lenses; Cardiovascular Systems recalls some Diamondback devices on embolism risk

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp